CYP2C19*16/*26 AND Citalopram response
- Germline classification:
- drug response (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000782596.10
Allele description [Variation Report for CYP2C19*16/*26]
NM_000769.4(CYP2C19):c.1324C>T (p.Arg442Cys)
NM_000769.4(CYP2C19):c.766G>A (p.Asp256Asn)
Condition(s)
- Name:
- Citalopram response
- Synonyms:
- Celexa response
- Identifiers:
- MedGen: CN221263
Assertion and evidence details
Last Updated: Apr 15, 2024